117 related articles for article (PubMed ID: 28056880)
1. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.
Thumallapally N; Meshref A; Mousa M; Terjanian T
BMC Cancer; 2017 Jan; 17(1):13. PubMed ID: 28056880
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and survival of primary extraosseous plasmacytoma: insights from a population-based study with a 20-year follow-up.
Huang L; Wei J; Wang F
Leuk Lymphoma; 2023 Dec; 64(12):2026-2036. PubMed ID: 37584346
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.
Knobel D; Zouhair A; Tsang RW; Poortmans P; Belkacémi Y; Bolla M; Oner FD; Landmann C; Castelain B; Ozsahin M;
BMC Cancer; 2006 May; 6():118. PubMed ID: 16677383
[TBL] [Abstract][Full Text] [Related]
4. A population-based study on incidence trends of myeloma in the United States over 2000-2020.
Mousavi SE; Ilaghi M; Aslani A; Yekta Z; Nejadghaderi SA
Sci Rep; 2023 Nov; 13(1):20705. PubMed ID: 38001246
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and outcomes of solitary plasmacytoma in a tertiary hospital in the UK.
Agbuduwe C; Yang H; Gaglani J; Ajithkumar T
Clin Med (Lond); 2020 Sep; 20(5):e191-e195. PubMed ID: 32934063
[TBL] [Abstract][Full Text] [Related]
6. Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy.
Fang P; Pinnix CC; Wu SY; Lee HC; Patel KK; Saini N; Becnel MR; Kaufman G; Thomas SK; Orlowski RZ; Amini B; Lin P; Dabaja BS; Gunther JR
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):193-199. PubMed ID: 38070713
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21
Weberpals J; Pulte D; Jansen L; Luttmann S; Holleczek B; Nennecke A; Ressing M; Katalinic A; Merz M; Brenner H;
Haematologica; 2017 Jun; 102(6):e229-e232. PubMed ID: 28280077
[No Abstract] [Full Text] [Related]
8. Solitary Plasmacytoma of the Spine in a Young Male and the Outcome of Inpatient Rehabilitation Stay.
Senol S; Ampomah K; Montes-Chinea N
Cureus; 2023 Sep; 15(9):e45673. PubMed ID: 37868411
[TBL] [Abstract][Full Text] [Related]
9. Association of radiotherapy for prostate cancer and second primary colorectal cancer: a US population-based analysis.
Tang W; Zhou LJ; Zhang WQ; Jia YJ; Ge MW; Hu FH; Chen HL
Tech Coloproctol; 2023 Dec; 28(1):14. PubMed ID: 38095784
[TBL] [Abstract][Full Text] [Related]
10. Primary intracranial lymphomas-incidence and survival: a population-based study.
Jiang Y; Zheng X; Lu T; Gao P; Wang Y
Neurosurg Rev; 2023 Oct; 46(1):265. PubMed ID: 37804440
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database.
Wang Z; Gong C; Zhang Y; Wang M; Chao C; Qian Y; Di D; Wang B
Oncol Res Treat; 2023; 46(12):520-529. PubMed ID: 37963448
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of survival for grade III solitary fibrous tumor/hemangiopericytoma: a population-based retrospective Surveillance, Epidemiology, and End Results database analysis.
Bhutada AS; Hoggarth AR; Adhikari S; Cuoco JA; Entwistle JJ; Marvin EA; Rogers CM
Oncology; 2023 Dec; ():. PubMed ID: 38160661
[TBL] [Abstract][Full Text] [Related]
13. Surgery is a Viable Treatment Option for Stage IE Primary Thyroid Lymphoma.
Tang Y; Yan T; Qiu W; Ding Z; Fan Y; Jiao Q; Yang Z
Ann Surg Oncol; 2024 Feb; 31(2):1108-1115. PubMed ID: 37925658
[TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment of primary cardiac angiosarcoma: A systematic literature review.
Stergioula A; Kokkali S; Pantelis E
Cancer Treat Rev; 2023 Nov; 120():102617. PubMed ID: 37603906
[TBL] [Abstract][Full Text] [Related]
15. Impact of bone events on survival in solitary bone plasmacytoma.
Mauro GP; Neffá PP; Villar RC; Martinez GA; Carvalho HA
Rep Pract Oncol Radiother; 2020; 25(3):389-395. PubMed ID: 32322178
[TBL] [Abstract][Full Text] [Related]
16. The Singular Epidemiology of Plasmacytoma and Multiple Myeloma in French Guiana.
Imounga LM; Drak Alsibai K; Plenet J; Wang Q; Virjophe-Cenciu B; Couppie P; Sabbah N; Adenis A; Nacher M
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201605
[TBL] [Abstract][Full Text] [Related]
17. Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry.
Ballas L; Ailawadhi S; Narang M; Gasparetto CJ; Lee HC; Hardin JW; Durie BGM; Toomey K; Omel J; Wagner LI; Abonour R; Terebelo HR; Joshi P; Yu E; Liu L; Rifkin RM; Jagannath S
Pract Radiat Oncol; 2024; 14(2):e141-e149. PubMed ID: 37984714
[TBL] [Abstract][Full Text] [Related]
18. Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14).
Touzeau C; Le Gouill S; Mahé B; Boudreault JS; Gastinne T; Blin N; Caillon H; Dousset C; Amiot M; Moreau P
Haematologica; 2017 Mar; 102(3):e112-e114. PubMed ID: 28057737
[No Abstract] [Full Text] [Related]
19. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.
Caers J; Paiva B; Zamagni E; Leleu X; Bladé J; Kristinsson SY; Touzeau C; Abildgaard N; Terpos E; Heusschen R; Ocio E; Delforge M; Sezer O; Beksac M; Ludwig H; Merlini G; Moreau P; Zweegman S; Engelhardt M; Rosiñol L
J Hematol Oncol; 2018 Jan; 11(1):10. PubMed ID: 29338789
[TBL] [Abstract][Full Text] [Related]
20. Osteoblastic Solitary Plasmacytoma of Bone.
Sioka C; Sakelariou K; Papoudou-Bai A; Tolis C; Al-Boucharali J; Fotopoulos A
Turk J Haematol; 2019 May; 36(2):117-119. PubMed ID: 30820260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
